Phase
Condition
N/ATreatment
N/AClinical Study ID
Ages 78-10 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Molecular diagnosis of DMD
Patients 6.5 - 10 years of age at time of screening
Ambulant
Ability to walk 150 m in the 6 min walking distance (6MWT)
D1 subdomain of the MFM scale >40%
stable treatment with steroids for >6 months or steroid naïve patients
Exclusion
Exclusion Criteria:
Previous (3 months or less) or concomitant participation in another therapeutic trial
Use of L-citrulline, L-arginine or metformin within the last 3 months
Known individual hypersensitivity to L-citrulline or metformin
known or suspected malignancy
Other chronic disease or clinical relevant limitation of renal, liver, heart functionaccording to discretion of investigator
start of cortisone treatment or change in dosage <6 months prior to screening
Study Design
Study Description
Connect with a study center
University Children's Hospital
Basel, BS 4031
SwitzerlandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.